162 related articles for article (PubMed ID: 16542183)
21. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.
Digney A; Keriakous D; Scarr E; Thomas E; Dean B
Biol Psychiatry; 2005 Apr; 57(7):711-5. PubMed ID: 15820227
[TBL] [Abstract][Full Text] [Related]
22. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
23. Glucose/oxygen deprivation and reperfusion upregulate SNAREs and complexin in organotypic hippocampal slice cultures.
Park SJ; Jung YJ; Kim YA; Lee-Kang JH; Lee KE
Neuropathology; 2008 Dec; 28(6):612-20. PubMed ID: 18503508
[TBL] [Abstract][Full Text] [Related]
24. Vesicle associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activation-induced degranulation of mature human mast cells.
Sander LE; Frank SP; Bolat S; Blank U; Galli T; Bigalke H; Bischoff SC; Lorentz A
Eur J Immunol; 2008 Mar; 38(3):855-63. PubMed ID: 18253931
[TBL] [Abstract][Full Text] [Related]
25. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
Thompson PM; Egbufoama S; Vawter MP
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
[TBL] [Abstract][Full Text] [Related]
26. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
[TBL] [Abstract][Full Text] [Related]
27. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue.
Lu M; Forsberg L; Höög A; Juhlin CC; Vukojević V; Larsson C; Conigrave AD; Delbridge LW; Gill A; Bark C; Farnebo LO; Bränström R
Mol Cell Endocrinol; 2008 Jun; 287(1-2):72-80. PubMed ID: 18457912
[TBL] [Abstract][Full Text] [Related]
29. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder.
Anitha A; Nakamura K; Yamada K; Iwayama Y; Toyota T; Takei N; Iwata Y; Suzuki K; Sekine Y; Matsuzaki H; Kawai M; Miyoshi K; Katayama T; Matsuzaki S; Baba K; Honda A; Hattori T; Shimizu S; Kumamoto N; Tohyama M; Yoshikawa T; Mori N
Biol Psychiatry; 2008 Apr; 63(7):678-85. PubMed ID: 17884020
[TBL] [Abstract][Full Text] [Related]
30. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.
Sawada K; Young CE; Barr AM; Longworth K; Takahashi S; Arango V; Mann JJ; Dwork AJ; Falkai P; Phillips AG; Honer WG
Mol Psychiatry; 2002; 7(5):484-92. PubMed ID: 12082566
[TBL] [Abstract][Full Text] [Related]
31. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes.
Ryan MM; Lockstone HE; Huffaker SJ; Wayland MT; Webster MJ; Bahn S
Mol Psychiatry; 2006 Oct; 11(10):965-78. PubMed ID: 16894394
[TBL] [Abstract][Full Text] [Related]
32. Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia.
De Luca V; Likhodi O; Van Tol HH; Kennedy JL; Wong AH
Acta Psychiatr Scand; 2006 Sep; 114(3):211-5. PubMed ID: 16889592
[TBL] [Abstract][Full Text] [Related]
33. Abnormal expression of cell recognition molecules in schizophrenia.
Vawter MP; Cannon-Spoor HE; Hemperly JJ; Hyde TM; VanderPutten DM; Kleinman JE; Freed WJ
Exp Neurol; 1998 Feb; 149(2):424-32. PubMed ID: 9500955
[TBL] [Abstract][Full Text] [Related]
34. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
35. Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
Smith R; Klein P; Koc-Schmitz Y; Waldvogel HJ; Faull RL; Brundin P; Plomann M; Li JY
J Neurochem; 2007 Oct; 103(1):115-23. PubMed ID: 17877635
[TBL] [Abstract][Full Text] [Related]
36. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum.
Minzer K; Lee O; Hong JJ; Singer HS
J Neurol Sci; 2004 Apr; 219(1-2):55-61. PubMed ID: 15050438
[TBL] [Abstract][Full Text] [Related]
37. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
[TBL] [Abstract][Full Text] [Related]
38. Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder.
Thomas AJ; Davis S; Ferrier IN; Kalaria RN; O'Brien JT
Biol Psychiatry; 2004 Mar; 55(6):652-5. PubMed ID: 15013836
[TBL] [Abstract][Full Text] [Related]
39. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.
Beneyto M; Meador-Woodruff JH
Synapse; 2006 Dec; 60(8):585-98. PubMed ID: 16983646
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment.
Bezchlibnyk YB; Xu L; Wang JF; Young LT
Brain Res; 2007 May; 1147():213-7. PubMed ID: 17395163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
